Stockreport

Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease [Yahoo! Finance Canada]

MeiraGTx Holdings plc - Ordinary Shares  (MGTX) 
PDF Shares ?of the gene therapy developer rose 12.5% to $9.55 in premarket trading on Monday after the news. Under the deal, MeiraGTx will get an upfront payment of $75 m [Read more]